About

Amy Ronneberg has served as a director of Actuate Therapeutics since August 2024. She has been Chief Executive Officer of NMDP (formerly Be The Match), a nonprofit that facilitates bone-marrow transplantation, since March 2020, having previously served as its Chief Financial Officer from 2013 to 2020 and as President of NMDP BioTherapies, LLC. Earlier she held roles at Capella Education Company, including Chief Accounting Officer and Vice President of Operations, and was an Audit Manager at Ernst & Young. She serves as a director and finance committee chair of Allina Health and previously served on the board of Magenta Therapeutics, Inc. from 2018 to 2023. Ms. Ronneberg earned an M.B.A. from Capella University, a Corporate Directorship Certificate from Harvard Business School, and a B.B.A. in Accounting from the University of Wisconsin-Eau Claire.

Roles

Actuate Therapeutics, Inc.
Director · Current role
August 2024–present
NMDP (formerly Be The Match)
Chief Executive Officer
2020 - present
NMDP
Chief Financial Officer
2013 - 2020
Capella Education Company
Chief Accounting Officer & VP of Operations
2000 - 2012
Ernst & Young
Audit Manager
1995 - 2000

External Roles

Allina Health
Director; Finance Committee Chair
2020 - present

Director Compensation

FY 2025
Fees earned or paid in cash
$55,500
ComponentAnnual cash retainers and committee/chair fees earned in 2025
Option awards
$103,995
ComponentAnnual stock option grant (15,000 shares, May 22, 2025), ASC 718 grant-date fair value
Total
$159,495

Also at Actuate Therapeutics, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.